| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |